Acute and chronic studies using a new oral hypoglycemic agent, glyburide.
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000652:urine; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000652:urine; D001772:Blood Cell Count; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000008:administration & dosage / Q000633:toxicity; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000494:pharmacology / Q000633:toxicity; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000187:drug effects; D010629:Phenformin / Q000627:therapeutic use; D010919:Placebos; D013450:Sulfones / Q000008:administration & dosage / Q000633:toxicity; D013943:Thymol / Q000032:analysis; D014508:Urea / Q000008:administration & dosage* / Q000633:toxicity
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D010919:Placebos; D013450:Sulfones; D013943:Thymol; D014508:Urea; D002784:Cholesterol; D010629:Phenformin; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin